Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1955 1
1956 1
1957 1
1959 1
1960 2
1961 2
1962 3
1963 4
1964 6
1965 21
1966 10
1967 10
1968 10
1969 9
1970 7
1971 17
1972 17
1973 15
1974 24
1975 19
1976 16
1977 22
1978 26
1979 25
1980 38
1981 37
1982 51
1983 61
1984 60
1985 56
1986 65
1987 68
1988 56
1989 73
1990 57
1991 57
1992 64
1993 85
1994 105
1995 91
1996 112
1997 104
1998 152
1999 133
2000 133
2001 120
2002 149
2003 142
2004 122
2005 121
2006 135
2007 143
2008 130
2009 140
2010 185
2011 186
2012 234
2013 216
2014 210
2015 191
2016 181
2017 201
2018 231
2019 249
2020 297
2021 342
2022 265
2023 232
2024 229
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,988 results

Results by year

Filters applied: . Clear all
Page 1
SAPHO syndrome and pustulotic arthro-osteitis.
Kishimoto M, Taniguchi Y, Tsuji S, Ishihara Y, Deshpande GA, Maeda K, Okada M, Komagata Y, Kobayashi S, Okubo Y, Tomita T, Kaname S. Kishimoto M, et al. Among authors: okada m. Mod Rheumatol. 2022 Jul 1;32(4):665-674. doi: 10.1093/mr/roab103. Mod Rheumatol. 2022. PMID: 34967407 Review.
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA. Teachey DT, et al. Among authors: okada m. J Clin Oncol. 2022 Jul 1;40(19):2106-2118. doi: 10.1200/JCO.21.02678. Epub 2022 Mar 10. J Clin Oncol. 2022. PMID: 35271306 Free PMC article. Clinical Trial.
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50).
Kato K, Doki Y, Ogata T, Motoyama S, Kawakami H, Ueno M, Kojima T, Shirakawa Y, Okada M, Ishihara R, Kubota Y, Amaya-Chanaga C, Chen T, Matsumura Y, Kitagawa Y. Kato K, et al. Among authors: okada m. Esophagus. 2023 Apr;20(2):291-301. doi: 10.1007/s10388-022-00970-1. Epub 2022 Nov 19. Esophagus. 2023. PMID: 36401133 Free PMC article. Clinical Trial.
Aortite chez une patiente recevant une chimiothérapie.
Fukui S, Kidoguchi G, Okada M. Fukui S, et al. Among authors: okada m. CMAJ. 2023 Feb 27;195(8):E315-E316. doi: 10.1503/cmaj.220584-f. CMAJ. 2023. PMID: 36849171 Free PMC article. French. No abstract available.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
Hattori A, Suzuki K, Takamochi K, Wakabayashi M, Sekino Y, Tsutani Y, Nakajima R, Aokage K, Saji H, Tsuboi M, Okada M, Asamura H, Nakamura K, Fukuda H, Watanabe SI; Japan Clinical Oncology Group; West Japan Oncology Group. Hattori A, et al. Among authors: okada m. Lancet Respir Med. 2024 Feb;12(2):105-116. doi: 10.1016/S2213-2600(23)00382-X. Epub 2024 Jan 3. Lancet Respir Med. 2024. PMID: 38184010 Clinical Trial.
Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial.
Suzuki K, Saji H, Aokage K, Watanabe SI, Okada M, Mizusawa J, Nakajima R, Tsuboi M, Nakamura S, Nakamura K, Mitsudomi T, Asamura H; West Japan Oncology Group; Japan Clinical Oncology Group. Suzuki K, et al. Among authors: okada m. J Thorac Cardiovasc Surg. 2019 Sep;158(3):895-907. doi: 10.1016/j.jtcvs.2019.03.090. Epub 2019 Apr 9. J Thorac Cardiovasc Surg. 2019. PMID: 31078312 Free article. Clinical Trial.
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Nash P, Kirkham B, Okada M, Rahman P, Combe B, Burmester GR, Adams DH, Kerr L, Lee C, Shuler CL, Genovese M; SPIRIT-P2 Study Group. Nash P, et al. Among authors: okada m. Lancet. 2017 Jun 10;389(10086):2317-2327. doi: 10.1016/S0140-6736(17)31429-0. Epub 2017 May 24. Lancet. 2017. PMID: 28551073 Clinical Trial.
Sugar-mediated non-canonical ubiquitination impairs Nrf1/NFE2L1 activation.
Yoshida Y, Takahashi T, Ishii N, Matsuo I, Takahashi S, Inoue H, Endo A, Tsuchiya H, Okada M, Ando C, Suzuki T, Dohmae N, Saeki Y, Tanaka K, Suzuki T. Yoshida Y, et al. Among authors: okada m. Mol Cell. 2024 Aug 22;84(16):3115-3127.e11. doi: 10.1016/j.molcel.2024.07.013. Epub 2024 Aug 7. Mol Cell. 2024. PMID: 39116872
Necrotizing Otitis Externa.
Suyama Y, Okada M, Nozaki T, Furukawa K. Suyama Y, et al. Among authors: okada m. Intern Med. 2019 Mar 15;58(6):895-896. doi: 10.2169/internalmedicine.1684-18. Epub 2018 Nov 19. Intern Med. 2019. PMID: 30449798 Free PMC article. No abstract available.
5,988 results